Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/1998
08/18/1998US5795896 Consisting of thrombin inhibitor and absorption inhibiting agent
08/18/1998US5795872 DNA construct for immunization
08/18/1998US5795868 Platelet aggregation inhibitors
08/18/1998US5795867 Platelet aggregation inhibitors
08/18/1998US5795866 ETS1 gene: a human tumor suppressor gene
08/18/1998US5795865 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
08/18/1998US5795864 Stable omega conopetide formulations
08/18/1998US5795863 Recombinant agents affecting thrombosis
08/18/1998US5795862 Ectoparasite saliva proteins and apparatus to collect such proteins
08/18/1998US5795861 Methods for regulating gastrointestinal motility
08/18/1998US5795860 Analogs for specific oligosaccharide-protein interactions and uses therefor
08/18/1998US5795859 Peptide which abrogates TNF and/or LPS toxicity
08/18/1998US5795790 Method for controlling proliferation and differentiation of cells encapsulated within bioartificial organs
08/18/1998US5795782 Measuring physical properties
08/18/1998US5795779 Human interferon-β (IFN-β) produced in Chinese hamster ovary (CHO) cells
08/18/1998US5795778 Using enzymatic rna compound
08/18/1998US5795777 Gene coded for interleukin-2 polypeptide, recombinant DNA carrying the said gene, a living cell line possessing the recombinant DNA, and method for producing interleukin-2 using the said cell
08/18/1998US5795776 For producing a eukaryotic polypeptide
08/18/1998US5795771 Culture medium for Saccharomyces cerevisiae
08/18/1998US5795770 Genetically engineered eukaryotic organism capable of detecting the expression of heterologous ion channels and method to use the same
08/18/1998US5795769 Gene encoding interleukin-2 polypeptide, recombinant DNA carrying the gene, a living cell line possessing the recombinant DNA and method for producing interleukin-2 using the cell
08/18/1998US5795768 Genetic engineering
08/18/1998US5795763 Synthesis-deficient thermostable DNA polymerase
08/18/1998US5795758 DNA encoding histidyl tRNA synthetase variant from Streptococcus pneumoniae
08/18/1998US5795753 Reversible nuclear genetic system for male sterility in transgenic plants
08/18/1998US5795752 Genetic engineering
08/18/1998US5795746 Synthetic leader peptide sequences
08/18/1998US5795745 Human growth hormone
08/18/1998US5795743 A (glyco)protein
08/18/1998US5795741 Nucleic acid molecules with codes for proteins with amino acid sequences for vaccines
08/18/1998US5795740 Pituitary differentiation factor and methods of use thereof
08/18/1998US5795738 Engineered peptide synthetases and their use for the non-ribosomal production of peptides
08/18/1998US5795737 High level expression of proteins
08/18/1998US5795736 Peptide amino acid sequences, replacements and expression vectors
08/18/1998US5795735 Isolated polynucleotides encoding PKA-binding proteins and methods of producing the proteins recombinantly
08/18/1998US5795734 Tyrosine kinases, cell differentiation
08/18/1998US5795731 Inteins as antimicrobial targets: genetic screens for intein function
08/18/1998US5795726 Methods for identifying compounds useful in treating type II diabetes
08/18/1998US5795723 Measuring transcripts or proteins expresedfrom genes
08/18/1998US5795721 High affinity nucleic acid ligands of ICP4
08/18/1998US5795719 Biotinylated latex microsphere, process for the preparation of such a microsphere and use as agent for biological detection
08/18/1998US5795707 Photographic silver halide material
08/18/1998US5795611 Produced from microorganisms; genetic engineering
08/18/1998US5795580 Group B streptococcus type V polysaccharide-protein conjugate vaccines
08/18/1998US5795579 Herpes simplex virus VP16 vaccines
08/18/1998US5795578 Vaccine against equine herpesvirus type 1
08/18/1998US5795577 Viral vector coding for a glycoprotein of the virus responsible for A.I.D.S.
08/18/1998US5795569 Polypeptides
08/18/1998US5795568 Method of treating infectious disease with GM-CSF
08/18/1998CA2224123A1 Nucleic acid construct for the cell cycle regulated expression of structural genes
08/18/1998CA2215920A1 Drug binding protein
08/18/1998CA2131455C Selective crosslinking of hemoglobin by oxidized, ring-opened saccharides
08/18/1998CA2032167C Dna coding for protein binds to enhancer of.alpha.-fetoprotein gene
08/18/1998CA1340007C Linear analogs of atrial natruiretic peptides
08/18/1998CA1340003C Method and means for microbial polypeptide expression
08/14/1998CA2197615A1 Human interferon-.alpha. gene promoters transcript control dna sequences
08/13/1998WO1998035236A2 Immunological assay for spongiform encephalopathies
08/13/1998WO1998035235A1 Assay for collagen type ii fragments
08/13/1998WO1998035229A1 Diagnosis of disease using tears
08/13/1998WO1998035062A1 Multistep, atp-dependent cell-free system for the assembly of human immunodeficiency virus capsids
08/13/1998WO1998035061A2 Member of the tnf family useful for treatment and diagnosis of disease
08/13/1998WO1998035052A1 Production of self-compatible brassica hybrids using a self-incompatible pollination control system
08/13/1998WO1998035046A1 Novel bacillus thuringiensis isolates active against sucking insects
08/13/1998WO1998035045A2 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
08/13/1998WO1998035043A1 Human sdf-5 protein and compositions
08/13/1998WO1998035042A2 Activity dependent neurotrophic factor iii (adnf iii)
08/13/1998WO1998035041A1 Human lea-motif developmental protein
08/13/1998WO1998035040A2 A single gene encoding aortic-specific and striated-specific muscle cell isoforms and uses thereof
08/13/1998WO1998035039A1 Dendritic cell-derived growth factor
08/13/1998WO1998035038A1 Human dosage compensation-associated protein
08/13/1998WO1998035037A1 TYROSINE PHOSPHORYLATED CLEAVAGE FURROW-ASSOCIATED PROTEINS (PSTPIPs)
08/13/1998WO1998035036A1 Heregulin variants
08/13/1998WO1998035035A1 Novel mouse cxc chemokine receptor
08/13/1998WO1998035034A1 Mammal neuronal acid sensing cationic channel, cloning and applications thereof
08/13/1998WO1998035033A1 Polynucleotides encoding proexendin, and methods and uses thereof
08/13/1998WO1998035032A2 Methods of inducing cell cycle stasis
08/13/1998WO1998035029A1 Synthetic genes for recombinant mycobacterium proteins
08/13/1998WO1998035028A2 An oncolytic/immunogenic complementary-adenoviral vector system
08/13/1998WO1998035027A2 Human nerve growth factor exon 1 and exon 3 promoters
08/13/1998WO1998035026A1 Polypeptide-polymer conjugates having added and/or removed attachment groups
08/13/1998WO1998035019A1 Growth differentiation factor-11
08/13/1998WO1998035014A2 Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom
08/13/1998WO1998034968A1 Polymers incorporating peptides
08/13/1998WO1998034955A1 No-modified hemoglobins and uses therefor
08/13/1998WO1998034954A2 Ligands for discoidin domain receptor tyrosine kinases and complexes thereof
08/13/1998WO1998034953A1 Crystallisation of proteins
08/13/1998WO1998034952A2 Il-2 gene expression and delivery systems and uses
08/13/1998WO1998034951A1 A new cytokine family and uses thereof
08/13/1998WO1998034950A1 Isolated candida albicans oligopeptide transporter gene
08/13/1998WO1998034948A1 Library screening as a strategy to clone drugs for g protein coupled receptors
08/13/1998WO1998034946A1 Daxx, a novel fas-binding protein that activates jnk and apoptosis
08/13/1998WO1998034655A1 Matrix-free osteogenic devices, implants and methods of use thereof
08/13/1998WO1998034643A1 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of dms
08/13/1998WO1998034640A2 Synthetic hiv gag genes
08/13/1998WO1998034637A1 Use of a polypeptide for obtaining a composition for detecting, preventing or treating a degenerative and/or autoimmune disease
08/13/1998WO1998034634A1 Compositions and methods for inhibiting cellular proliferation
08/13/1998WO1998034631A1 Peptide mimetics of the cytokine receptor gamma chain
08/13/1998WO1998030709A3 Non-immunogenic prodrugs and selectable markers for use in gene therapy
08/13/1998WO1998030693A3 Tumor necrosis factor receptor 5
08/13/1998WO1998026798A3 IMMUNIZATION AGAINST NEISSERIA GONORRHOEAE AND $i(NEISSERIA MENINGITIDIS)